Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | PTPRB | P23467 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6944045 | 0.85 | MEN1 (0.37) | BCHEACHEFFAR1KDM4EPOLB | |
| SCHEMBL6950120 | 0.78 | PTPRB (0.34) | KDM4EPOLBPTPRBTSHR | |
| SCHEMBL7137466 | 0.77 | ALDH1A1 (0.38) | BCHEACHEFFAR1KDM4EPOLB | |
| SCHEMBL6948228 | 0.69 | KDM4E (0.37) | KDM4EPOLBPTPRBTSHR | |
| SCHEMBL9548555 | 0.69 | ACHE (0.46) | BCHEACHEFFAR1PTGS2TSHR | |
| SCHEMBL4661710 | 0.68 | L3MBTL1 (0.52) | BCHEACHETSHR | |
| SCHEMBL1791345 | 0.67 | SLC6A2 (0.43) | KDM4EPOLBTSHR | |
| SCHEMBL866663 | 0.67 | TSHR (0.42) | TSHR | |
| SCHEMBL6948598 | 0.66 | ACHE (0.44) | BCHEACHEFFAR1PTGS2 | |
| SCHEMBL29171867 | 0.66 | NAAA (0.42) | BCHEACHEFFAR1PTGS2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1115729-B1 | PHOSPHONIC ACID DERIVATIVES AS INHIBITORS OF PTP-1B | MERCK FROSST CANADA INC (CA) | 2003-02-19 | — | — | EP | disclosed |
| US-6174874-B1 | ANTIDIABETIC,-CARCINOGENIC AGENTS; IMPROVING GLUCOSE TOLERANCE/INSULIN-SENSITIVITY; PREVENTING/TREATING OBESITY AND NEURODEGENERATIVE DISEASES; E.G. 1,3-BIS-((PHOSPHONODI-FLUOROMETHYL)PHENYL)-2-DICARBOXYPROPANE | MERCK FROSST CANADA & CO. (CA) | 2001-01-16 | — | — | US | disclosed |